Upon his return to the United States Presidency, Donald Trump signed a number of executive orders that will not have an immediate impact, but will take effect in the coming weeks.

A flurry of executive orders and other actions Trump issued on his first day back in office included rescinding directives by his predecessor, former President Joe Biden, that had promoted lowering drug costs and expanding coverage under the Affordable Care Act and Medicaid.

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

President Donald Trump issued a flurry of executive orders and other actions on healthcare, signaling he intends to reverse many of Joe Biden’s moves.

Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker announced results from a Phase 3B trial of semaglutide at a 7.2 milligram dosage,

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

Veterans Affairs officials issued guidance Thursday exempting more than 300,000 department health care posts from the White House's federal hiring freeze, labeling them as essential to public health and department operations.

Don Dempsey, head of policy and research at lobbying group Better Medicare Alliance — funded by insurance companies including UnitedHealth Group and Humana — was the leading candidate to be Trump’s top health official at the US Office of Management and Budget, said three people familiar with the matter.

Biden spent like no president in history, and, with a sleight of hand, by taking hundreds of billions out of Medicare and spending it on green energy subsidies.

The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid agencies to research and implement models for lowering the costs of prescription drugs. Separate provisions in the Inflation Reduction Act of 2022 also aimed at lower prescription drug costs are still in effect.